Patent US4021546A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4021546A Expired / Lapsed US ⏱️ 0.0 years remaining

Pro-drug forms of digoxin and method of preparing and using same

Assignee: Interx Research Corp
•
Filing: 1976-03-08
•
Granted: 1977-05-03
•
Expires: 1996-03-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is provided, a novel pro-drug form of digoxin having the following formula: ##STR1## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring amino acid, and a ##STR2## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which each of X and Y are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: When R is a member other than a hydrogen atom, all of said R's must be the same member. These novel compounds will be cleaved in the bloodstream of a warm-blooded animal, thus delivering digoxin in a cardiotonic effective amount. Due to their higher solubility and superior absorption characteristics, the compounds of the instant invention permit a higher and more reproducible level of digoxin bioavailability to be attained in comparison with that which could be attained if digoxin per se was administered.

Inventors

  • 👤 Nicolae S. Bodor

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 19:00
CPC Classifications
C; C07; C07J; C07J19/00; C07J19/005; C07J41/00; C07J41/0033; C07J41/0088; C07J43/00; C07J43/003

Claims Analysis

Total Claims: 65
Claim 1
Independent Claim 130 words
A pro-drug of digoxin having the formula: ##STR8## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring protein amino acid, and a ##STR9## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which each of X and Y are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: when R is a member other than a hydrogen atom, all of said R's must be the same member.
Claim 2
Dependent Claim 130 words
A pro-drug of digoxin having the formula: ##STR8## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring protein amino acid, and a ##STR9## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which each of X and Y are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: when R is a member other than a hydrogen atom, all of said R's must be the same member.
Claim 3
Dependent Claim 19 words
The compound of claim 1, wherein R represents a ##STR10## group and X and Y represent a methyl group.
Claim 4
Dependent Claim 19 words
The compound of claim 1, wherein R represents a ##STR11## group and X and Y represents an ethyl group.
Claim 5
Dependent Claim 7 words
The compound of claim 1: Digoxin mono-(N,N-dimethyl)-glycinate.
Claim 6
Dependent Claim 7 words
The compound of claim 1: Digoxin mono-(N,N-diethyl)-glycinate.
Claim 7
Dependent Claim 7 words
The compound of claim 1: Digoxin mono-(1-piperidyl)-acetate.
Claim 8
Dependent Claim 6 words
The compound of claim 1: Digoxin-di-(N,N-dimethyl)-glycinate.
Claim 9
Dependent Claim 6 words
The compound of claim 1: Digoxin-di-(N,N-diethyl)-glycinate.
Claim 10
Dependent Claim 6 words
The compound of claim 1: Digoxin-di-(1-piperidyl)-acetate.
Claim 11
Dependent Claim 7 words
The compound of claim 1: Digoxin mono-N-formylglycinate.
Claim 12
Dependent Claim 7 words
The compound of claim 1: Digoxin di-N-formylglycinate.
Claim 13
Dependent Claim 7 words
The compound of claim 1: Digoxin tetra-(N,N-dimethyl)-glycinate.
Claim 14
Dependent Claim 7 words
The compound of claim 1: Digoxin penta-(N,N-dimethyl)-glycinate.
Claim 15
Dependent Claim 7 words
The compound of claim 1: Digoxin tetra-(1-piperidyl)-acetate.
Claim 16
Dependent Claim 7 words
The compound of claim 1: Digoxin penta-(1-piperidyl)-acetate.
Claim 17
Dependent Claim 7 words
The compound of claim 1: Digoxin tri-N-formylglycinate.
Claim 18
Dependent Claim 7 words
The compound of claim 1: Digoxin tetra-N-formylglycinate.
Claim 19
Dependent Claim 7 words
The compound of claim 1: Digoxin penta-N-formylglycinate.
Claim 20
Dependent Claim 144 words
A pharmaceutical composition consisting essentially of a pharmaceutically acceptable oral inert diluent and a cardiotonic effective amount of a pro-drug of digoxin having the formula: ##STR12## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring protein amino acid, and a ##STR13## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which they are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: when R is a member other than a hydrogen atom, all of said R's must be the same member.
Claim 21
Dependent Claim 144 words
A pharmaceutical composition consisting essentially of a pharmaceutically acceptable oral inert diluent and a cardiotonic effective amount of a pro-drug of digoxin having the formula: ##STR12## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring protein amino acid, and a ##STR13## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which they are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: when R is a member other than a hydrogen atom, all of said R's must be the same member.
Claim 22
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin mono-(N,N-dimethyl)-glycinate.
Claim 23
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin mono-(N,N-diethyl)-glycinate.
Claim 24
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin mono-(1-piperidyl)-acetate.
Claim 25
Dependent Claim 10 words
The composition of claim 19, wherein said compound is: Digoxin-di-(N,N-dimethyl)-glycinate.
Claim 26
Dependent Claim 10 words
The composition of claim 19, wherein said compound is: Digoxin-di-(N,N-diethyl)-glycinate.
Claim 27
Dependent Claim 10 words
The composition of claim 19, wherein said compound is: Digoxin-di-(1-piperidyl)-acetate.
Claim 28
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin mono-N-formylglycinate.
Claim 29
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin tetra-(N,N-dimethyl)-glycinate.
Claim 30
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin penta-(N,N-dimethyl)-glycinate.
Claim 31
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin tetra-(1-piperidyl)-acetate.
Claim 32
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin penta-(1-piperidyl)-acetate.
Claim 33
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin tri-N-formylglycinate.
Claim 34
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin tetra-N-formylglycinate.
Claim 35
Dependent Claim 11 words
The composition of claim 19, wherein said compound is: Digoxin penta-N-formylglycinate.
Claim 36
Independent Claim 147 words
A method for treating cardiac insufficiency in a warm-blooded animal which comprises orally administering thereto, an effective cardiotonic amount of a pro-drug of digoxin having the following formula: ##STR14## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring protein amino acid, and a ##STR15## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which they are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: when R is a member other than a hydrogen atom, all of said R's must be the same member.
Claim 37
Independent Claim 147 words
A method for treating cardiac insufficiency in a warm-blooded animal which comprises orally administering thereto, an effective cardiotonic amount of a pro-drug of digoxin having the following formula: ##STR14## wherein R represents a member selected from the group consisting of a hydrogen atom, a residue of any naturally occurring protein amino acid, and a ##STR15## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which they are attached, and a non-toxic inorganic or organic pharmaceutically acceptable acid addition salt thereof, with the proviso that: when R is a member other than a hydrogen atom, all of said R's must be the same member.
Claim 38
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin mono-(N,N-dimethyl)-glycinate.
Claim 39
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin mono-(N,N-diethyl)-glycinate.
Claim 40
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin mono-(1-piperidyl)-acetate.
Claim 41
Dependent Claim 10 words
The method of claim 34, wherein said compound is: Digoxin-di-(N,N-dimethyl)-glycinate.
Claim 42
Dependent Claim 10 words
The method of claim 34, wherein said compound is: Digoxin-di-(N,N-diethyl)-glycinate.
Claim 43
Dependent Claim 10 words
The method of claim 34, wherein said compound is: Digoxin-di-(1-piperidyl)-acetate.
Claim 44
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin mono-N-formylglycinate.
Claim 45
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin di-N-formylglycinate.
Claim 46
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin tetra-(N,N-dimethyl)-glycinate.
Claim 47
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin penta-(N,N-dimethyl)-glycinate.
Claim 48
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin tetra-(1-piperidyl)-acetate.
Claim 49
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin penta-(1-piperidyl)-acetate.
Claim 50
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin tri-N-formylglycinate.
Claim 51
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin tetra-N-formylglycinate.
Claim 52
Dependent Claim 11 words
The method of claim 34, wherein said compound is: Digoxin penta-N-formylglycinate.
Claim 53
Dependent Claim 19 words
The method of claim 34, wherein said compound is maintained in combination with a pharmaceutically acceptable oral inert diluent.
Claim 54
Dependent Claim 19 words
The method of claim 34, wherein said compound is present in an amount of from 250 to 500 micrograms.
Claim 55
Dependent Claim 19 words
The method of claim 50, wherein said compound is present in an amount of from 250 to 500 micrograms.
Claim 56
Independent Claim 263 words
A method for preparing a pro-drug compound of digoxin having the formula: ##STR16## where R represents a ##STR17## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which each of X and Y are attached, with the proviso that when R is a member other than a hydrogen atom, all of said R's must be the same member which comprises the steps of (1) reacting, in the presence of a suitable organic coupling agent and a weak organic base-solvent, a stoichiometric amount of digoxin with a stoichiometric amount of an N,N-dialkylamino acid having the formula ##STR18## or its pharmaceutically acceptable acid addition salt, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which they are attached, said reaction being carried out at room temperature, standard pressure and over a period of time of from one hour to four days, and wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent ranges from 1:1 to 1:5, and (2) removing the final product thus formed during the reaction of step (1) above from the reaction mixture.
Claim 57
Independent Claim 263 words
A method for preparing a pro-drug compound of digoxin having the formula: ##STR16## where R represents a ##STR17## group, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which each of X and Y are attached, with the proviso that when R is a member other than a hydrogen atom, all of said R's must be the same member which comprises the steps of (1) reacting, in the presence of a suitable organic coupling agent and a weak organic base-solvent, a stoichiometric amount of digoxin with a stoichiometric amount of an N,N-dialkylamino acid having the formula ##STR18## or its pharmaceutically acceptable acid addition salt, wherein X and Y, which may be the same or different, each represent a member selected from the group consisting of a methyl group and an ethyl group, or wherein X and Y may form a (CH 2 ) 4 or (CH 2 ) 5 heterocyclic ring with the N atom to which they are attached, said reaction being carried out at room temperature, standard pressure and over a period of time of from one hour to four days, and wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent ranges from 1:1 to 1:5, and (2) removing the final product thus formed during the reaction of step (1) above from the reaction mixture.
Claim 58
Dependent Claim 24 words
The method of claim 53, wherein said weak organic base-solvent is a member selected from the group consisting of pyridine, quinoline, isoquinoline, and N-methylpyrrole.
Claim 59
Dependent Claim 21 words
The method of claim 53, wherein said coupling agent is a member selected from the group consisting of dicyclohexylcarbodiimide and N-ethoxy-carbonyl-2-ethoxy-1,3-dihydroquinoline.
Claim 60
Dependent Claim 19 words
The method of claim 53, wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent is 1:1.
Claim 61
Dependent Claim 19 words
The method of claim 53, wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent is 1:2.
Claim 62
Dependent Claim 19 words
The method of claim 53, wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent is 1:3.
Claim 63
Dependent Claim 19 words
The method of claim 53, wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent is 1:4.
Claim 64
Dependent Claim 19 words
The method of claim 53, wherein the mole ratio of said N,N-dialkylamino acid to said coupling agent is 1:5.
Claim 65
Dependent Claim 28 words
The method of claim 53, wherein said pro-drug compound is further reacted with a non-toxic pharmaceutically acceptable acid, thus forming the corresponding non-toxic pharmaceutically acceptable acid addition salt.

References Cited (Backward Citations)

US3884905A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-05-02 1980-11-01 1981-05-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-05-02 1984-11-01 1985-05-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-05-02 1988-11-01 1989-05-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag